Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 11
2004 7
2005 7
2006 9
2007 11
2008 9
2009 10
2010 7
2011 6
2012 15
2013 10
2014 12
2015 8
2016 12
2017 18
2018 10
2019 10
2020 9
2021 10
2022 13
2023 3
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

196 results

Results by year

Filters applied: . Clear all
Page 1
Pseudo-resistance to anticancer drugs.
Davoli E, Zucchetti M, Giavazzi R, Garattini S, Frapolli R. Davoli E, et al. Among authors: garattini s. Ther Adv Med Oncol. 2022 Nov 14;14:17588359221136776. doi: 10.1177/17588359221136776. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 36407785 Free PMC article. No abstract available.
Noninferiority Trials.
Garattini S, Bertele’ V. Garattini S, et al. N Engl J Med. 2018 Jan 18;378(3):303. doi: 10.1056/NEJMc1714668. N Engl J Med. 2018. PMID: 29345450 No abstract available.
Disappointing biotech.
Joppi R, Bertele' V, Garattini S. Joppi R, et al. Among authors: garattini s. BMJ. 2005 Oct 15;331(7521):895-7. doi: 10.1136/bmj.331.7521.895. BMJ. 2005. PMID: 16223825 Free PMC article. Review.
Immunotherapy for colorectal cancer: where are we heading?
Basile D, Garattini SK, Bonotto M, Ongaro E, Casagrande M, Cattaneo M, Fanotto V, De Carlo E, Loupakis F, Urbano F, Negri FV, Pella N, Russano M, Brunetti O, Scartozzi M, Santini D, Silvestris N, Casadei Gardini A, Puzzoni M, Calvetti L, Cardarelli N, Aprile G. Basile D, et al. Among authors: garattini sk. Expert Opin Biol Ther. 2017 Jun;17(6):709-721. doi: 10.1080/14712598.2017.1315405. Epub 2017 Apr 13. Expert Opin Biol Ther. 2017. PMID: 28375039 Free article. Review.
Conditional approval of medicines by the EMA.
Banzi R, Gerardi C, Bertele' V, Garattini S. Banzi R, et al. Among authors: garattini s. BMJ. 2017 May 2;357:j2062. doi: 10.1136/bmj.j2062. BMJ. 2017. PMID: 28465401 No abstract available.
How can we regulate medicines better?
Garattini S, Bertele' V. Garattini S, et al. BMJ. 2007 Oct 20;335(7624):803-5. doi: 10.1136/bmj.39281.615706.94. BMJ. 2007. PMID: 17947785 Free PMC article. Review.
Funding is not enough.
Garattini S, Bertele' V. Garattini S, et al. Eur J Intern Med. 2018 Nov;57:e8. doi: 10.1016/j.ejim.2018.07.011. Epub 2018 Jul 13. Eur J Intern Med. 2018. PMID: 30017560 No abstract available.
Controlling cervical cancer.
Bonati M, Garattini S. Bonati M, et al. Among authors: garattini s. Pharmacoeconomics. 2009;27(2):91-3. doi: 10.2165/00019053-200927020-00001. Pharmacoeconomics. 2009. PMID: 19254043 No abstract available.
Clinical research on rare diseases of children: neuroblastoma.
Gerardi C, Banzi R, Bertele' V, Garattini S. Gerardi C, et al. Among authors: garattini s. Cancer Chemother Pharmacol. 2017 Feb;79(2):267-273. doi: 10.1007/s00280-016-3195-3. Epub 2016 Nov 22. Cancer Chemother Pharmacol. 2017. PMID: 27878358 Review.
We are more than our omics.
Garattini S. Garattini S. Eur J Clin Pharmacol. 2020 Jul;76(7):1043-1044. doi: 10.1007/s00228-020-02852-w. Epub 2020 Apr 27. Eur J Clin Pharmacol. 2020. PMID: 32338304
196 results